References
- Weatherall DJ. Haemoglobin and the inherited disorders of globin synthesis. In: Hoffbrand AV, Catovsky D, Tuddenham EGD, Eds. Postgraduate Haematology, 5th ed. Oxford, UK: Blackwell Publishing Ltd. 2005:85–103
- Galanello R, Origa R. β-Thalassemia. Orphanet J Rare Dis. 2010;5:11
- Weatherall DJ, Williams TN, Allen SJ, O’Donnell A. The population genetics and dynamics of the thalassemias. Hematol Oncol Clin North Am. 2010;24(6):1021–1031
- El-Beshlawy A, Youssry I. Prevention of hemoglobinopathies in Egypt. Hemoglobin. 2009;33(S1):S14–S20
- Rachmilewitz EA, Schrier S. The pathophysiology of β-thalassemia. In: Steinberg MH, Forget BG, Higgs DR, Nagel RL, Eds. Disorders of Hemoglobin Genetics, Pathophysiology, and Clinical Management. Cambridge, UK: Cambridge University Press. 2001:233–251
- Rund D, Rachmilewitz E. β-Thalassemia. N Engl J Med 2005;353(11):1135–1146
- Schrier SL. Pathophysiology of thalassemia. Curr Opin Hematol 2002;9(2):123–126
- Kim DD, Song WC. Membrane complement regulatory proteins. Clin Immunol. 2006;118(2–3):127–136
- Lachmann PJ. The control of homologous lysis. Immunol Today. 1991;12(9):312–315
- Ruiz-Delgado GJ, Vazquez-Garza E, Mendez-Ramirez N, Gomez-Almaguer D. Abnormalities in the expression of CD55 and CD59 surface molecules on peripheral blood cells are not specific to paroxysmal nocturnal hemoglobinuria. Hematology. 2009;14(1):33–37
- Pourazar AA, Andalib AR, Oreizy F, et al. A flowcytometry study of CD55 and CD59 expression on erythrocytes in rheumatoid arthritis patients. Iranian J Immunol. 2005;2(2):91–96
- Ruiz-Arguelles A, Llorente L. The role of complement regulatory proteins (CD55 and CD59) in the pathogenesis of autoimmune hemocytopenias. Autoimmun Rev. 2007;6(3):155–161
- Terpos E, Sarantopoulos A, Kouramba A, et al. Reduction of CD55 and/or CD59 in red blood cells of patients with HIV infection. Med Sci Monit. 2008;14(5):CR276–CR280
- Wang RH, Phillips G Jr, Medof ME, Mold C. Activation of the alternative complement pathway by exposure of phosphati-dylethanolamine and phosphatidylserine on erythrocytes from sickle cell disease patients. J Clin Invest. 1993;92(3):1326–1335
- Issitt PD, Combs MR, Bumgarner DJ, et al. Studies of antibodies in the sera of patients who have made red cell autoantibodies. Transfusion. 1996;36(6):481–486
- Alegretti AP, Mucenic T, Merzoni J, et al. Expression of CD55 and CD59 on peripheral blood cells from systemic lupus erythematosus (SLE) patients. Cell Immunol. 2010;265(2):127–132
- Richaud-Patin Y, Perez-Romano B, Carrillo-Maravilla E, et al. Deficiency of red cell bound CD55 and CD59 in patients with systemic lupus erythematosus. Immunol Lett. 2003;88(2):95–99
- Ruiz-Arguelles A, Llorente L. The role of complement regulatory proteins (CD55 and CD59) in the pathogenesis of autoimmune hemocytopenias. Autoimmun Rev. 2007;6(3):155–161
- Ruiz-Argüelles A, León-Lloret M, Richaud-Patin Y, et al. Acquired deficiency of CD55 and CD59 in autoimmune hemocytopenias. In: Veskler BA, Ed. Leading-Edge Immunology Research. New York, NY: Nova Publishers Inc. 2006:79–94
- Dervillez X, Oudin S, Libyh MT, et al. Catabolism of the human erythrocyte C3b/C4b receptor (CR1, CD35): Vesiculation and/or proteolysis? Immunopharmacology. 1997;38(2):129–140
- Nuutila J, Jalava-Karvinen P, Libyh MT, et al. Use of complement regulators, CD35, CD46, CD55, and CD59, on leukocytes as markers for diagnosis of viral and bacterial infections. Hum Immunol. 2013;74(5):522–530
- Goldsby RA, Kindt RA, Kuby G, Osborne BA, Eds. Kuby’s Immunology, 5th ed. New York, NY: W.H. Freeman. 2006:306